Lucid Diagnostics Inc. is a New York-based, commercial-stage medical diagnostics company that focuses on gastroesophageal reflux disease patients who are at risk of developing cancer. They offer two lead products for this cause: EsoGuard and EsoCheck. The company was incorporated in 2018 and is a subsidiary of PAVmed Inc.